Snircova, E., Nosáľová, G., Ondrejka, I., & Kulhan, T. ATOMOXETINE IN THE TREATMENT OF THE MOST COMMON COMORBID DISORDERS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, OPPOSITIONAL DEFIANT DISORDER AND ANXIETY DISORDERS.
Chicago Style (17th ed.) CitationSnircova, E., Gabriela Nosáľová, Igor Ondrejka, and T. Kulhan. ATOMOXETINE IN THE TREATMENT OF THE MOST COMMON COMORBID DISORDERS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, OPPOSITIONAL DEFIANT DISORDER AND ANXIETY DISORDERS.
MLA (9th ed.) CitationSnircova, E., et al. ATOMOXETINE IN THE TREATMENT OF THE MOST COMMON COMORBID DISORDERS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, OPPOSITIONAL DEFIANT DISORDER AND ANXIETY DISORDERS.
Warning: These citations may not always be 100% accurate.
